SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000921530-00-000195
Filing Date
2000-09-15
Accepted
2000-09-15 00:00:00
Documents
1
Group Members
BROWN SIMPSON ASSET MANAGEMENT, LLCBROWN SIMPSON CAPITAL, LLCBROWN SIMPSON STRATEGIC GROWTH FUND L PBROWN SIMPSON STRATEGIC GROWTH FUND, L.P.BROWN SIMPSON STRATEGIC GROWTH FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 AMD #1 TO SCH 13G RE SCICLONE PHARMACEUTICALS, INC 0001.txt SC 13G/A 17485
  Complete submission text file 0000921530-00-000195.txt   19910
Mailing Address
Business Address 901 MARINERS ISLAND BLVD SUITE 315 SAN MATEO CA 94404 6503583456
SCICLONE PHARMACEUTICALS INC (Subject) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43408 | Film No.: 723896
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET 40TH FL NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 40TH FLOOR NEW YORK NY 10019
BROWN SIMPSON STRATEGIC GROWTH FUND L P (Filed by) CIK: 0001074478 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231